LIMBREX Trademark

Trademark Overview

On Wednesday, October 1, 2003, a trademark application was filed for LIMBREX with the United States Patent and Trademark Office. The USPTO has given the LIMBREX trademark a serial number of 78308125. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 19, 2010. This trademark is owned by Primus Pharmaceuticals, Inc.. The LIMBREX trademark is filed in the Pharmaceutical Products category with the following description:

Medical foods for use in the dietary management of patients with osteoarthritis, rheumatoid arthritis, or other forms of arthritis or inflammatory diseases; pharmaceutical preparations for the treatment of osteoarthritis, rheumatoid arthritis, or other forms of arthritis or inflammatory diseases

General Information

Serial Number78308125
Word MarkLIMBREX
Filing DateWednesday, October 1, 2003
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 19, 2010
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 6, 2004

Trademark Statements

Goods and ServicesMedical foods for use in the dietary management of patients with osteoarthritis, rheumatoid arthritis, or other forms of arthritis or inflammatory diseases; pharmaceutical preparations for the treatment of osteoarthritis, rheumatoid arthritis, or other forms of arthritis or inflammatory diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 17, 2003
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePrimus Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressScottsdale, AZ 85251
Party NamePrimus Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressScottsdale, AZ 85250

Trademark Events

Event DateEvent Description
Monday, July 19, 2010ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 19, 2010ABANDONMENT - NO USE STATEMENT FILED
Thursday, November 12, 2009EXTENSION 5 GRANTED
Friday, October 23, 2009EXTENSION 5 FILED
Thursday, November 12, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, October 23, 2009TEAS EXTENSION RECEIVED
Thursday, January 29, 2009EXTENSION 4 GRANTED
Thursday, January 29, 2009EXTENSION 4 FILED
Thursday, January 29, 2009TEAS EXTENSION RECEIVED
Wednesday, November 19, 2008EXTENSION 3 GRANTED
Wednesday, November 19, 2008EXTENSION 3 FILED
Wednesday, November 19, 2008TEAS EXTENSION RECEIVED
Wednesday, April 2, 2008EXTENSION 2 GRANTED
Wednesday, April 2, 2008EXTENSION 2 FILED
Wednesday, April 2, 2008TEAS EXTENSION RECEIVED
Tuesday, December 18, 2007EXTENSION 1 GRANTED
Thursday, November 29, 2007EXTENSION 1 FILED
Thursday, November 29, 2007TEAS EXTENSION RECEIVED
Tuesday, July 3, 2007ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, July 3, 2007TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 19, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 16, 2007OPPOSITION TERMINATED NO. 999999
Monday, April 16, 2007OPPOSITION DISMISSED NO. 999999
Monday, August 30, 2004PAPER RECEIVED
Wednesday, August 18, 2004OPPOSITION INSTITUTED NO. 999999
Wednesday, July 28, 2004EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, July 6, 2004PUBLISHED FOR OPPOSITION
Wednesday, June 16, 2004NOTICE OF PUBLICATION
Monday, April 19, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 16, 2004EXAMINERS AMENDMENT E-MAILED
Friday, April 16, 2004ASSIGNED TO EXAMINER

Related Keywords

limbrex arthritis diseases other forms rheumatoid osteoarthritis inflammatory treatment pharmaceutical preparations